{
    "paper_id": "197acc4c279deac64dcdb284514dc3f49ea361f7",
    "metadata": {
        "title": "Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources DRC II 7035",
        "authors": [
            {
                "first": "Baha",
                "middle": [],
                "last": "Abdalhamid",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Nebraska Medical Center",
                    "location": {}
                },
                "email": "babdalhamid@unmc.edu"
            },
            {
                "first": "Christopher",
                "middle": [
                    "R"
                ],
                "last": "Bilder",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Nebraska-Lincoln",
                    "location": {
                        "settlement": "Lincoln",
                        "region": "NE"
                    }
                },
                "email": ""
            },
            {
                "first": "Emily",
                "middle": [
                    "L"
                ],
                "last": "Mccutchen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Nebraska Medical Center",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Steven",
                "middle": [
                    "H"
                ],
                "last": "Hinrichs",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Nebraska Medical Center",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Scott",
                "middle": [
                    "A"
                ],
                "last": "Koepsell",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Nebraska Medical Center",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Peter",
                "middle": [
                    "C"
                ],
                "last": "Iwen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Nebraska Medical Center",
                    "location": {}
                },
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "22",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "To establish the optimal parameters for group testing of pooled specimens for the detection of 24 SARS-CoV-2.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "23"
        },
        {
            "text": "The most efficient pool size was determined to be 5 specimens using a web-based application.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "26"
        },
        {
            "text": "From this analysis, 25 experimental pools were created using 50 microliter from one SARS-CoV-28 2 positive nasopharyngeal specimen mixed with 4 negative patient specimens (50 microliter each) 29 for a total volume of 250 microliter l. Viral RNA was subsequently extracted from each pool and 30 tested using the CDC SARS-CoV-2 RT-PCR assay. Positive pools were consequently split into 31 individual specimens and tested by extraction and PCR. This method was also tested on an 32 unselected group of 60 nasopharyngeal specimens grouped into 12-pools.",
            "cite_spans": [
                {
                    "start": 192,
                    "end": 194,
                    "text": "29",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "27"
        },
        {
            "text": "All 25 pools were positive with Cycle threshold (Ct) values within 0 and 5.03 Ct of the original 35 individual specimens. The analysis of 60 specimens determined that two pools were positive 36 followed by identification of two individual specimens among the 60 tested. This testing was 37 accomplished while using 22 extractions/PCR tests, a savings of 38 reactions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "34"
        },
        {
            "text": "When the incidence rate of SARS-CoV-2 infection is 10% or less, group testing will result in the 40 saving of reagents and personnel time with an overall increase in testing capability of at least 69%.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "39"
        },
        {
            "text": "All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "42"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https: //doi.org/10.1101 //doi.org/10. /2020 Since the first detection in Wuhan, China in December 2019, severe acute respiratory 43 syndrome coronavirus 2 (SARS-CoV-2), the pathogen of coronavirus diseases 2019 , 44 has spread worldwide to now be considered a pandemic 1, 2 swabs. The second step in the assay employs reverse transcription and amplification using a real 54 time PCR instrumentation. The assay therefore requires two kits, one for extraction and another 55 for amplification of the target and detection. We investigated whether a strategy used in the testing 56 of blood prior to transfusion could have application for conservation of scarce reagents for the 57 SARS CoV-2 assay 4,5 . The process of group testing that employs sample pooling is used for 58 detection of the human immunodeficiency virus, and hepatitis B and C viruses 4 in blood products.",
            "cite_spans": [
                {
                    "start": 85,
                    "end": 102,
                    "text": "//doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 103,
                    "end": 122,
                    "text": "//doi.org/10. /2020",
                    "ref_id": null
                },
                {
                    "start": 292,
                    "end": 294,
                    "text": "44",
                    "ref_id": null
                },
                {
                    "start": 348,
                    "end": 350,
                    "text": "1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 351,
                    "end": 352,
                    "text": "2",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "42"
        },
        {
            "text": "Key principles for successful application of group testing involve knowledge of the limit-of-60 detection, sensitivity and specificity of the assay, and the prevalence of disease in the population.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "59"
        },
        {
            "text": "The goal of the process is to determine a pool size that provides the greatest conservation of 62 resources while maintaining the reliable performance of testing. This report describes a proof-of-63 concept for group testing of pooled specimens for the diagnosis of COVID-19. 64 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "61"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.20050195 doi: medRxiv preprint 4 To assess the group testing strategy, the first step was to calculate the most efficient pool 65 size using a web-based application for pooling as described at https://www.chrisbilder.com/shiny.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "61"
        },
        {
            "text": "Although the prevalence of COVID-19 in Nebraska has not been specifically defined by 67 comprehensive epidemiology studies, the observed specimen positive rate within the tested 68 community has been around 5% for the past two weeks.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "66"
        },
        {
            "text": "The following parameters and 69 assumptions used in this calculation included an experimental prevalence rate of 5%, an assay 70 lower limit-of-detection of 1 to 3 RNA copies/\u00b5l, an assay sensitivity of 95% or 100%, an assay 71 specificity of 100%, a two-stage pooling algorithm, and a range of pool sizes of 3 to 10 samples 6 .",
            "cite_spans": [],
            "ref_spans": [],
            "section": "66"
        },
        {
            "text": "These calculations predicted a pool size of 5 samples would provide the largest reduction in the 73 expected number of tests of 57% when compared to testing specimen separately ( Figure 1 ).",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 179,
                    "end": 187,
                    "text": "Figure 1",
                    "ref_id": null
                }
            ],
            "section": "72"
        },
        {
            "text": "The CDC RT-PCR assay was used in this study to detect SARS- author/funder, who has granted medRxiv a license to display the preprint in perpetuity. were positive within a range of 0 Ct to 5.03 Ct difference from the original samples (Table 1) . To 92 examine this approach in a clinical situation, 60 specimens from individuals at risk for COVID-19 93 as determined by the public health department were separated randomly into 12 pools, which were 94 processed as described. Two of the pools were characterized as \"2019-nCoV detected\" by the The practical application of this process was confirmed with 60 samples from the 108 community resulting in the saving of reagents and personnel time that could expand testing to an 109 additional 38 samples. Assuming a consistent positivity rate, this strategy would expand testing 110 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 233,
                    "end": 242,
                    "text": "(Table 1)",
                    "ref_id": "TABREF3"
                }
            ],
            "section": "74"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.20050195 doi: medRxiv preprint 6 by 133%. Table 2 summarizes the impact of different positive test rates on the overall efficiency 111 of test resources.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 155,
                    "end": 162,
                    "text": "Table 2",
                    "ref_id": null
                }
            ],
            "section": "74"
        },
        {
            "text": "During a rapidly changing epidemic, testing strategies will need to adapt to potential 113 increases in the positive test rate. Group testing of pooled specimens also requires the use of highly 114 sensitive assays to avoid missing low positive samples. Therefore, strategies must be employed to The authors thank the staff of the Biology Section within the Nebraska Public Health 126 Laboratory for processing of the specimens and performance of the assay. According to the 127 University of Nebraska Medical Center Institutional Review Board, this study was deemed exempt 128 because it was conducted as a part of a diagnostic testing study.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "112"
        },
        {
            "text": "The FDA reviewed the procedure as part of a EUA approved diagnostic procedure. All authors 130 declare no conflict of interest.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "129"
        },
        {
            "text": "References 132 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "131"
        },
        {
            "text": "The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.20050195 doi: medRxiv preprint ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "131"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "COVID-19-New Insights on a Rapidly Changing Epidemic",
            "authors": [
                {
                    "first": "Del",
                    "middle": [],
                    "last": "Rio",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Malani",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "N"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "133",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.3072"
                ]
            }
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Diagnostic Testing for the Novel Coronavirus",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Sharfstein",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Becker",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Mello",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Safety Considerations in the Laboratory Testing of 137",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "C"
                    ],
                    "last": "Iwen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Stiles",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Pentella",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome 138",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "SARS-CoV-2)",
            "authors": [],
            "year": 2020,
            "venue": "Am J Clin Pathol",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "13910.1093/ajcp/aqaa047"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Pooling nasopharyngeal/throat swab specimens to 141 increase testing capacity for influenza viruses by PCR",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "T"
                    ],
                    "last": "Van",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Warshauer",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Clin Microbiol",
            "volume": "50",
            "issn": "3",
            "pages": "891--142",
            "other_ids": {
                "DOI": [
                    "10.1128/JCM.05631-11"
                ]
            }
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Hepatitis B, hepatitis C and HIV transfusion-145 transmitted infections in the 21st century",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Dwyre",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "P"
                    ],
                    "last": "Fernando",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "V"
                    ],
                    "last": "Holland",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Vox Sang",
            "volume": "100",
            "issn": "1",
            "pages": "92--98",
            "other_ids": {
                "DOI": [
                    "14610.1111/j.1423-0410.2010.01426.x"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "The objective function controversy for group testing: 149 Much ado about nothing",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "D"
                    ],
                    "last": "Hitt",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Bilder",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Tebbs",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Stat Med",
            "volume": "38",
            "issn": "24",
            "pages": "4912--4923",
            "other_ids": {
                "DOI": [
                    "10.1002/sim.8341"
                ]
            }
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "The assay developed by the Centers for Disease Control and Prevention (CDC) for 50 detection of SARS-CoV-2 and approved for use under emergency use authorization (EUA) by the 51 FDA has been widely employed by public health laboratories throughout the US 3 . This assay 52 employs an extraction procedure of viral RNA from specimens collected by nasopharyngeal (NP) 53",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "95assay. All individual specimens within each of the two identified pools were re-tested with two 96 positive samples identified for an overall positive rate of 3.3%. The total reactions used were 22 97 for an overall conservation of 38 extraction kits and 38 amplification reagents.98Group testing of pooled samples has been successfully employed by the blood procurement 99 and infectious disease testing for many years 5 . The strategy became effective due to the 100 development of highly sensitive molecular based assays and several studies reported on statistical 101 measures to determine appropriate parameters for use 6 . This study examined whether pooling was 102 feasible using an EUA SARS CoV-2 assay in a public health setting where the desire to test large 103 numbers of individuals has been impacted by the scarcity of key resources. The predictive 104 algorithm indicated a pooling ratio of 1 to 5 was expected to retain accuracy of the test and result 105 in greater efficiency of test resources. Results of this study indicated that all positive samples by 106 the non-pooled method were detected in pools with four other negative samples.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "115 closely monitor the use of pooling as the positive rate of test specimens increases in an outbreak 116 of disease. Additionally, the impact of different extraction methods on the recovery of RNA and 117 overall test sensitivity need to be evaluated. Therefore, laboratories must perform their own 118 validation pool studies for kits used for each RNA extraction and amplification based on the 119 prevalence rate of COVID-19 in their own region. Finally, this study showed that pooling is an 120 effective approach to expand the impact of limited test resources and reagents during specific 121 stages of an infectious disease outbreak. 122 Funding 123 Christopher R. Bilder is supported by grant R01 AI121351 from the National Institutes of Health. 124 Acknowledgement 125",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": ". The United States (US) is experiencing an acute shortage of certain reagents important for performance of assays for the detection of SARS-CoV-2. Some areas of the US have stopped testing due to lack of test supplies. The ability to rapidly diagnosis COVID-19 is important for evaluating the spread of disease and for tracing the contacts of infected individuals.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "CoV-2 in nasopharyngeal 75 specimens. With this assay, a positive COVID-19 result is determined when both nucleocapsid",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "extraction was performed on each pool using either the QIAGEN EZ1 Virus Mini Kit v2.0 (QIAGEN, Germantown, MD) or the QIAGEN manual extraction kit according to manufacturer's instructions. Real-time RT-PCR was performed on the extracted NA using the CDC Diagnostic Panel following the manufacturer's instructions. The results showed that all 25-pooled specimens",
            "latex": null,
            "type": "table"
        },
        "TABREF3": {
            "text": "Comparison of threshold cycles between the original and pooled COVID-19 positive samples a . a : The extraction platforms included both automated and manual procedures. 170 171 b :The N1 and N2 targets were used to detect SARS-CoV-2 during the PCR assay.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https: //doi.org/10.1101 //doi.org/10. /2020 on the least number of tests and the following parameters: prevalence rate (5%), a lower 161 limit of detection of 1 to 3 RNA copies/\u00b5l, an assay sensitivity of either 95% or 100%, and 162 an assay specificity of 100%.",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 247,
                    "text": "//doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 248,
                    "end": 267,
                    "text": "//doi.org/10. /2020",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        },
        {
            "text": "All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.03.20050195 doi: medRxiv preprint 9 165 166 All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is the . https: //doi.org/10.1101 //doi.org/10. /2020 ",
            "cite_spans": [
                {
                    "start": 529,
                    "end": 546,
                    "text": "//doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 547,
                    "end": 566,
                    "text": "//doi.org/10. /2020",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "164"
        }
    ]
}